Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Progress in Medicinal Chemistry|January 9, 2003
Discovery of second generation quinazolinone non-nucleoside reverse transcriptase inhibitors of HIV-1Jeffrey W Corbett, James D RodgersNursing Outlook|August 7, 2007
Differentiating nursing leadership and management competenciesBonnie Mowinski Jennings, Cynthia C Scalzi, James D Rodgers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severityPhillip C C Liu, Eian Caulder, Jun Li, et al.The Journal of Investigative Dermatology|June 17, 2011
Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammationJordan S Fridman, Peggy A Scherle, Robert Collins, et al.Blood|February 5, 2010
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsAlfonso Quintás-Cardama, Kris Vaddi, Phillip Liu, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.Pageof 1